Abstract
Objective: Leveraging smartphone technology, we sought to examine the usability of the RELAXaHEAD application, which has a headache diary and PMR capability.
Background: Scalable non-pharmacologic treatment options are needed for chronic pain conditions. Migraine is an ideal condition to test smartphone-based mind body interventions (MBIs) because it is a very prevalent, costly, disabling condition. Progressive muscle relaxation (PMR) is a standardized, evidence-based MBI used for migraine which people can do independently and therefore might be best amenable for adaption in a smartphone application (app).
Design/Methods: Using the “Think Aloud” approach, we iteratively beta-tested RELAXaHEAD using a convenience sample of people with migraine who were affiliated with our academic medical center’s neurology and emergency medicine departments. One on one interviews were conducted, audio-recorded and transcribed. Using Grounded Theory, we conducted thematic analysis. Participants were also asked Likert scale questions about satisfaction with the app and the PMR.
Results: Twelve subjects who had a self-reported diagnosis of migraine participated in the study. The mean duration of the interviews was 36 (SD= 11, range 19–53) minutes. From the interviews, four main themes emerged. People with migraine were most interested in App Aesthetic/Appearance, App functionality, App Utility/Practicality, and the potential utility of the PMR. Furthermore, participants reported that the daily diary: was easy to use (75%), was relevant to track headaches (75%), maintained their interest and attention (75%), was easy to understand (83%). Ninety two percent of the participants would be happy to use the app again. Participants reported that PMR maintained their interest and attention (75%) and improved their stress and low mood (75%).
Conclusions: The RELAXaHEAD app appears to be acceptable and useful to migraine participants. Future studies can examine the use of the RELAXaHEAD app to deliver smartphone based MBI in a low cost, scalable manner.
Study Supported by: NA
Disclosure: Dr. Ortega has nothing to disclose. Dr. Jalloh has nothing to disclose. Dr. Minen has nothing to disclose.
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.